Stockreport

Dianthus (DNTH) Gains 18% in the Past Month: Here's Why [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF Its lead investigational candidate is DNTH103, which is being developed for several autoimmune indications, like generalized Myasthenia Gravis (gMG), multifocal motor n [Read more]